These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31163272)

  • 1. Cancer cell fusion: a potential target to tackle drug-resistant and metastatic cancer cells.
    Fernandes C; Prabhu P; Juvale K; Suares D; Yc M
    Drug Discov Today; 2019 Sep; 24(9):1836-1844. PubMed ID: 31163272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasion and metastasis of tumour cells resistant to chemotherapy.
    Nowakowska A; Tarasiuk J
    Postepy Hig Med Dosw (Online); 2017 May; 71(0):380-397. PubMed ID: 28513462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of a Schiff base scaffold, N-(2-hydroxy acetophenone) glycinate-in overcoming multidrug resistance in cancer.
    Ganguly A; Chakraborty P; Banerjee K; Choudhuri SK
    Eur J Pharm Sci; 2014 Jan; 51():96-109. PubMed ID: 24044945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of phosphatidylinositol 3-kinase/AKT/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells.
    Dong J; Zhai B; Sun W; Hu F; Cheng H; Xu J
    PLoS One; 2017; 12(9):e0185088. PubMed ID: 28934275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Resistance to cytostatics in hematologic neoplasm cells. Part III].
    Kodydková K; Krejsek J
    Cas Lek Cesk; 2000 Oct; 139(20):620-2. PubMed ID: 11192756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-glycoprotein associates with Anxa2 and promotes invasion in multidrug resistant breast cancer cells.
    Zhang F; Zhang H; Wang Z; Yu M; Tian R; Ji W; Yang Y; Niu R
    Biochem Pharmacol; 2014 Jan; 87(2):292-302. PubMed ID: 24239898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistance: clinical relevance in solid tumours and strategies for circumvention.
    Kaye SB
    Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S15-9. PubMed ID: 9801854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial-to-Mesenchymal Transition: Liaison between Cancer Metastasis and Drug Resistance.
    Du F; Liu H; Lu Y; Zhao X; Fan D
    Crit Rev Oncog; 2017; 22(3-4):275-282. PubMed ID: 29604904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Approaches With Natural Product Drugs for Overcoming Multidrug Resistance in Cancer.
    Dinic J; Podolski-Renic A; Stankovic T; Bankovic J; Pesic M
    Curr Pharm Des; 2015; 21(38):5589-604. PubMed ID: 26429711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micelle System Based on Molecular Economy Principle for Overcoming Multidrug Resistance and Inhibiting Metastasis.
    Qi Y; Qin X; Yang C; Wu T; Qiao Q; Song Q; Zhang Z
    Mol Pharm; 2018 Mar; 15(3):1005-1016. PubMed ID: 29397749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer.
    Coley HM
    Cancer Treat Rev; 2008 Jun; 34(4):378-90. PubMed ID: 18367336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of selected anti-tumour therapeutic agents and reasons for multidrug resistance occurrence.
    Sawicka M; Kalinowska M; Skierski J; Lewandowski W
    J Pharm Pharmacol; 2004 Sep; 56(9):1067-81. PubMed ID: 15324475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell fusion promotes chemoresistance in metastatic colon carcinoma.
    Carloni V; Mazzocca A; Mello T; Galli A; Capaccioli S
    Oncogene; 2013 May; 32(21):2649-60. PubMed ID: 22751128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colon cancer: cancer stem cells markers, drug resistance and treatment.
    Kozovska Z; Gabrisova V; Kucerova L
    Biomed Pharmacother; 2014 Oct; 68(8):911-6. PubMed ID: 25458789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The multi-factorial nature of clinical multidrug resistance in cancer.
    Assaraf YG; Brozovic A; Gonçalves AC; Jurkovicova D; Linē A; Machuqueiro M; Saponara S; Sarmento-Ribeiro AB; Xavier CPR; Vasconcelos MH
    Drug Resist Updat; 2019 Sep; 46():100645. PubMed ID: 31585396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the relationship between cancer invasion/metastasis and drug resistance.
    Liang Y; McDonnell S; Clynes M
    Curr Cancer Drug Targets; 2002 Sep; 2(3):257-77. PubMed ID: 12188911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells.
    Ahmed N; Escalona R; Leung D; Chan E; Kannourakis G
    Semin Cancer Biol; 2018 Dec; 53():265-281. PubMed ID: 30317036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.
    Pérez-Tomás R
    Curr Med Chem; 2006; 13(16):1859-76. PubMed ID: 16842198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR/HER2 inhibitors effectively reduce the malignant potential of MDR breast cancer evoked by P-gp substrates in vitro and in vivo.
    Jin Y; Zhang W; Wang H; Zhang Z; Chu C; Liu X; Zou Q
    Oncol Rep; 2016 Feb; 35(2):771-8. PubMed ID: 26718028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic potential and multidrug resistance correlation in the B16 melanoma system.
    Staroselsky AN; Mahlin T; Savion N; Klein O; Nordenberg J; Donin N; Michowitz M; Leibovici J
    J Exp Ther Oncol; 1996 Jul; 1(4):251-9. PubMed ID: 9414412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.